New Jersey A 2830: Requires health benefits coverage for buprenorphine and buprenorphine/naloxone for pain treatment without step therapy or fail-first protocols.

Status: Introduced in the Assembly, Referred to Assembly Financial Institutions and Insurance Committee (as of 2020-02-20)

State: New Jersey · Session: 219 · Bill: A 2830

Subjects: HEALTH INSUR, PHARMACEUTIC

Sponsors: Murphy, Carol A., Vainieri Huttle, Valerie, Chaparro, Annette

View New Jersey A 2830 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.